The authors argue that this off-label use exposes deeper tensions between medical innovation, body image ideals, and the social meanings attached to thinness, and explicitly ask whether such use should be considered an abuse of medical technology or a rational adaptation to weight-stigmatizing environments
These older GLP-1 drugs remain in use but have been largely overtaken by semaglutide and tirzepatide in new prescriptions
Glucagon-like peptide-1 (GLP-1) receptor agonists are a novel and promising class of drugs for T2DM, which may also have clinical applications in bone tissue disorders
Nickel-Metal Hydride (NiMH): Many beginners start with NiMH batteries because of their affordable cost
Because type 1 diabetes results from an absolute deficiency of endogenous insulin production, exogenous insulin therapy is a requirement for sustaining life and is, therefore, exempt from the heightened expectations of the Guidance for Industry